Marketresearchnews

Friday, 25 September 2020

Skin Tightening Treatment Market is Growing Massively till 2025

MarketResearchFuture.com added a new report titled as “Skin Tightening Treatment Market” with forecast to 2025. The study provides details such as the market share of companies in order to present a broader overview of the key players, Market Size, Regional Demand and Industry Revenue – Forecast to 2025

Market Highlights

The Global Skin Tightening Market is forecasted to be valued at USD 6,340.99 Million by 2025 with the CAGR of 6.2% during the forecast period of 2019–2025.

According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US. The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market.

Also read : https://www.medgadget.com/2019/10/skin-tightening-treatment-market-by-2019-trends-progresses-for-huge-profits-at-usd-6340-99-million-by-global-demand-to-2025.html

However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the skin tightening market.

In the current scenario, several players are dominating the global skin tightening market. The market leaders in skin tightening treatment are involved in merger and acquisition, product development and innovation to increase the foothold in the skin tightening market. For instance, in January 2017, Lynton Lasers launched a stand-alone platform, LUMINA laser & IPL platform, which can perform 24 different aesthetic concern including skin tightening.

Key Players – Skin Tightening Treatment Market

Some of the key players in the global skin tightening market are

ALLERGAN (US),
Solta Medical (US),
Venus Concept (Canada),
SmarterSkin Dermatology (US),
INMODE (US),
Fotona d.o.o. (Slovenia),
BTL (US),
Lynton Lasers (UK),
EINS MED Co., Ltd (South Korea),
ENDYMED MEDICAL (US),
Alma Lasers (Israel)

Segments – Skin Tightening Treatment Market

The global skin tightening market has been segmented based on type, portability, application, end user, and region.

The market, based on type, has been divided into radiofrequency skin tightening, laser skin tightening, ultrasound skin tightening, and others. The radiofrequency skin tightening segment is anticipated to hold the largest share in the market due to the wider preferability and long-lasting results.

The market, based on portability, has been segregated into portable and stand-alone. The stand-alone market is expected to hold the largest share in the market, owing to its increasing application in the medical devices industry.

The market, by application, has been categorized as reduce wrinkles, face lifting, anti-aging, and others. The anti-aging segment is expected to lead the market owing to the increasing focus and concern toward having a youthful appearance.

The market, by end user, has been classified as hospitals & clinics, specialty center, and others. The specialty center segment is anticipated to hold a major share in the market due to the professional skin tightening treatments provided in these establishments.

Regional Analysis – Skin Tightening Treatment Market

The global skin tightening market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The skin tightening market in the Americas is estimated to hold the largest market share. In 2016, according to ISAPS, the total number of skin tightening procedure performed are 75,834. The European skin tightening market has been sub-divided into Western Europe and Eastern Europe. Germany is expected to hold the largest market share in the European region followed by Italy.

The skin tightening market in Asia-Pacific region is expected to be the fastest-growing market, due to increasing research and development funding by the developing countries like China and India for the development of the healthcare sector. The skin tightening market in the Middle East & Africa region has less economic developments and extremely low-income, therefore anticipated to have the least market share but is expected to grow with better opportunities in the coming years.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/skin-tightening-market-8245

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Detail Study on Molecular Diagnostics Market is Projected to Grow Magnificent CAGR till 2025

Molecular Diagnostics Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Market Research Future (MRFR) has announced a new release on the Global Molecular Diagnostics Market. The research presents detailed forecasts regarding the market’s growth prospects in the 2020-2025 forecast period, on the basis of a comprehensive assessment of the market’s present conditions and segmentation.

Also read : https://www.medgadget.com/2019/03/molecular-diagnostics-market-growth-analysis-by-recent-trends-size-share-up-to-2023-by-hoffman-la-roche-ltd-grifols-hologic-inc-siemens-healthcare-gmbh-bd-abbott-etc.html

Molecular diagnostics is a branch of diagnostics which utilizes molecular biology to detect and measure the presence of genetic material or proteins related to a specific health condition. Molecular diagnostics is the fastest growing branch in vitro diagnosis as it has been able to achieve highest diagnosis accuracy and enables early diagnosis and prevention of diseases. The global molecular diagnostics market is expected to grow remarkably as it possesses the ability to conduct genetic tests that were previously not possible and it has the potential to replace the present microbiological and clinical methods of diagnosis. Market Research Future (MRFR), asserts that the global molecular diagnostics market is set to capture a CAGR of 9.6 % during the forecast period (2017-2023).

PCR-based testing is domineering the market at present; however, other similar technologies are expected to gain traction in the coming years. Developments such as integrated chip devices and proteomic-based testing will improve the future of molecular diagnostics but would also pose challenges for implementing such technologies. The market for molecular diagnostics is anticipated to continue its growth due to the rise in number of cancer patients and the change in the approach of the medical line from treatment to prevention.

Key players for Global Molecular Diagnostics Market

Leading companies in the global molecular diagnostics market include QIAGEN NV, Hoffman-La Roche Ltd., Grifols, Hologic Inc., Siemens Healthcare GmbH, BD, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Cepheid, and bioMerieux SA.

Several companies in the molecular diagnostics market are looking to collaborate with research institutes in order to advance their own product development programs. Recently, EZLife announced a collaboration with the UCLA to expand EGFR lung cancer assay into RUO offerings. Such collaborations are likely to be common among key players in the molecular diagnostics market.

Molecular Diagnostics Industry Updates

3 JAN 2019 CIRCULOGENE, advancing precision medicine through molecular genetics testing, has forged an international partnership with New Zealand-based CIRCULOGENE Asia Pacific Limited.
13 DEC 2018 In order to help clinical laboratories deliver accurate results during cold and flu season, Microbiologics Inc. has launched two new panels for quality control of Group A Streptococcus (GAS) and respiratory molecular assays and test methods.
Recently in 2018, Agilent Technologies Inc. acquired Lasergen Inc., a company devoted towards R&D of technologies for DNA sequencing. Through the collaboration, the company intends to strengthen its hold in the molecular diagnostic market and develop an integrated clinical workflow solution and provide mass access to molecular diagnostics.
Agendia, a leading medicine, and molecular cancer diagnostics has entered into a marketing agreement with Angsana Molecular & Diagnostic Laboratory, to market Agendia’s MammaPrint and BluePrint tests. These tests will aid physicians in treatment management for early breast cancer and Angsana will market these tests in Southeast Asia.
Myriad Genetics, Inc., a leading company pioneering molecular diagnostics has announced seven new payer coverage decisions for Prolaris, a standard 46-gene RNA-expression test for detection and measurement of prostate cancer. 25 leading insurer in the U.S. are included in the payers.

Segmental Analysis:

The Global Molecular Diagnostics Market is segmented on the basis of end use, application, and technique.

On the basis of technique, the global molecular diagnostics market is segmented into PCR and real-time PCR, microarray, fluorescence in-situ hybridization, next-generation sequencing, and transcription-mediated amplification. PCR dominates the global molecular diagnostics market and accounted for more than a third of the global market in 2018. The segment is likely to remain the dominant contributor in the global molecular diagnostics market over the forecast period, along with next-generation sequencing and transcription-mediated amplification.

On the basis of application, the global molecular diagnostics market is segmented into oncology, infectious diseases, genetic testing, blood screening, pharmacogenomics, coagulation, human leukocyte antigen typing, and others. Oncology and infectious diseases are likely to remain the major contributors to the global molecular diagnostics market over the forecast period thanks to the growing prevalence of diseases such as cancer and TB.

On the basis of end use, the global molecular diagnostics market is segmented into hospitals, diagnostic laboratories, and academics and research institutes.

Regional Analysis:

The Global Molecular Diagnostics Market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa.

Americas is likely to dominate the global molecular diagnostics market over the forecast period due to the presence of a highly sophisticated healthcare sector in North American countries such as the U.S. and Canada. Research in the life sciences sector in these countries is highly advanced and houses some of the world’s leading medical institutions. This has driven the molecular diagnostics market in the region at an impressive rate. The increasing prevalence of bone disorders, increasing government support to research and development, and growing concentration of major healthcare companies in the region are likely to propel the molecular diagnostics market in the Americas over the forecast period.

The increasing prevalence of cancer in Asia Pacific is likely to propel the molecular diagnostics market in APAC over the forecast period. According to the American Cancer Society, APAC accounts for nearly 44% of all cancer cases, with China bearing the brunt of the growing prevalence of the disease. South Korea has also witnessed a high incidence rate of cancer in recent years. This is likely to drive the molecular diagnostics market in Asia Pacific at a strong rate over the forecast period.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Future Scope of Type 1 Diabetes Treatment Market is Witness to Grow High CAGR till 2025

Global Type-1 Diabetes Treatment Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Type-1 Diabetes Treatment Market Has Better Growth Potential with Increased Government Assistance

Type-1 Diabetes Treatment Market Leaders

Several companies in the global market for Type-1 diabetes are impacting various moves. MRFR included several companies and tracked their performances to understand how the market is charting its future course. MRFR tracked various growth processes initiated by these companies to get a hold of trends that can impact the market.

Astellas Pharma (Japan),
Eli Lilly (US),
Merck (US),
Novo Nordisk (Denmark),
Sanofi (France),
AstraZeneca (UK),
Boehringer Ingelheim GmbH (Germany),
Novartis (Switzerland),
Pfizer Inc. (US),
Abbott Laboratories (US),
Mannkind Corporation (US),
Braun Melsungen AG (Germany),
Macrogenics, Inc. (US),
DiaVacs, Inc. (US),
Biodel, Inc. (US)

Also read : https://www.medgadget.com/2019/12/type-1-diabetes-treatment-market-exclusivity-industry-will-drive-huge-roi-at-usd-9-6-billion-during-2019-to-2025-market-research-future.html

In October 2019, researchers revealed a possibility of including a new treatment method that would act like an artificial pancreas with algorithms that would get adjusted as per the need and would increase the flow of insulin every day to make the treatment procedure more precise.

Type-1 Diabetes Treatment Market Size Analysis

The global type-1 diabetes treatment market, as per the Market Research Future (MRFR) report, can grow with a 7.9% CAGR and reach a market valuation of USD 9.6 Billion between 2019 and 2025. The report further elaborates on factors that can impact the global type-1 diabetes treatment market. The disease is known as a chronic condition that needs lifelong medication. It can affect an individual at any stage of his or her life. Both children and adults can be influenced by this and obese have a high chance of contracting the disease. This can be triggered further by a sedentary lifestyle. Other factors like changes in societal behavior, cultural output, and economic factors can also influence market growth. However, the market for type-1 diabetes treatment depends much on the significant number of players influencing market innovation. This is also getting deterred by regulations imposed by governments who are looking for better management of the situation. But government assistance in diverse ways can also trigger better market percolation.

Type-1 Diabetes Treatment Market Segmentation

By Product

Rapid-Acting Insulin: The largest and fastest-growing segment.
Short-Acting Insulin
Medium-Acting Insulin
Long-Acting Insulin
Others

By End User

Hospitals and Clinics: Currently the largest and fastest-growing segment.
Specialty Centers
Others

By Region

Americas
Europe
Asia-Pacific
Middle East & Africa

Type-1 Diabetes Treatment Market Regional Analysis

North America is a region with immense growth possibilities as the regional healthcare setup is top-class. The regional market is expecting a thriving growth in the coming years with growing awareness among people, better investment opportunities, increasing investment in research & technology to back up the market with innovation, availability of pharmaceutical support, better technological support, and others. Also, a lot of companies are taking substantial interest in the market to make sure that the regional market grows significantly in the coming years. Europe is holding a notable market position. The regional growth for the market would depend on various initiatives taken by research institutes and investors who are willingly contributing to the research and development sector. The Asia Pacific region has a better market scope with the massive population that is expected to trigger huge revenue generation. There are other factors like development in the healthcare sector and better awareness level of the disease can trigger market growth.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Theranostics Market | Worldwide Top key Players Profile Analysis | Forecast till 2025

The exclusive research report on the Global Theranostics Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The Global Theranostics Market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period. Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized medicine technology. Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment. Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases. In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.

Also read : https://www.medgadget.com/2019/08/theranostics-market-2019-global-analyses-by-new-development-business-opportunities-share-overview-demand-regional-demand-and-growth-insight-to-2025.html

Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules. Theranostics is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.

Key Players for Global Theranostics Market

Market Research Future (MRFR) recognizes the following companies as the key players in Theranostics Market: There are plenty of large and small market players which operate in this market all over the globe.

Few of the prominent players in the global theranostics market are

Thermo Fisher Scientific Inc.,
F. Hoffmann-La Roche Ltd,
Beckman Coulter, Inc.,
Focus Diagnostics,
Abbott Laboratories,
Illumina, Inc.,
Agilent Technologies, Inc.,
QIAGEN,
Myriad Genetics, Inc.,
Foundation Medicine, Inc., and
AmeriPath, Inc.

Segments for Global Theranostics Market

The Global Theranostics Market has been segmented into the therapeutic area, technology, end user, and region.

By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others. The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.

On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others. The sequencing segment is likely to register comparatively higher CAGR over the forecast period due to the increasing number of proof-of-concept case studies and research related to sequencing, particularly next-generation sequencing (NGS) technology.

Based on end user, the market has been classified into hospitals and clinics, diagnostic laboratories, and others.

Regional Analysis for Global Theranostics Market

The Global Theranostics Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would command the market throughout the forecast period attributed to the domicile of major market participants, increasing research and development activities, and growing adoption of theranostics in the US and Canada. For instance, in June 2018, Genome Canada launched a national initiative for clinical implementation of precision health that would ultimately impact the market growth in the near future.

Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and medical device companies, increasing partnerships and collaborations between life science companies and medical diagnostics companies, and growing personalized medicine sector. Personalized medicine (PM) is an emerging approach to prevention, diagnosis, treatment, and care which is assisting in addressing the challenge of the aging of the population, rising prevalence of chronic diseases, and increasing healthcare costs.

The market in Asia-Pacific would register the fastest market growth over next seven years owing to booming medical tourism, swiftly developing healthcare infrastructure, and growing awareness in the developing countries, namely, India, China, Singapore, and Australia.

The Middle East & Africa has the least share of the global theranostics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/theranostics-market-8057

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Feminine Hygiene Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Feminine Hygiene Market over the forecast period.

Global Feminine Hygiene Market 2020 Research Report: Information by Product Type (Sanitary Napkins/Pads, Tampons, Panty Liners, Others), Distribution Channel (Supermarket and Department Stores, Retail Pharmacies, Others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2024

Feminine Hygiene Market Overview:

Global feminine hygiene market had a valuation of USD 21.96 billion in 2018, and it would proceed ahead with a CAGR of 7.2% during the forecast period of 2019 to 2024. Market Research Future (MRFR) reveals a high level of awareness, growing demand for better products, increasing technological advancements, rising disposable income, and others as major factors that could boost the market.

Also read : https://www.medgadget.com/2020/03/feminine-hygiene-market-to-profit-from-hike-in-disposable-income-and-better-awareness-level-of-female-health-and-hygiene.html

Feminine Hygiene Market Segmentation:

The global market for feminine hygiene has been segmented into the distribution channel and product type. These segments have been analyzed well for a detailed look into various growth prospects that could help in develop better strategies.

By product type, the global report on feminine hygiene can be segmented into tampons, menstrual cups, panty liners, sanitary napkins/pads, and feminine hygiene wash. The sanitary napkins/pads segment has the maximum market coverage as these products are quite popular among women. The tampons segment is expected to grow with the fastest speed as it is gaining acceptance among athletes. It is a type of product that can absorb the menstrual flow if inserted into the vagina during the menstrual cycle. Feminine hygiene washes are products that help women stay clean by washing their private parts during the menstrual cycle. Pantyliners are an absorbent piece of fabric that soaks the menstrual flow. Menstrual cups are reusable, and it can be inserted in the vagina to catch the menstrual flow. Sanitary napkins/pads is also a hygiene product that absorbs the menstrual flow.

By distribution channel, the report on feminine hygiene market can be segmented into online retail stores, retail pharmacies, supermarket and department stores, and others. The supermarkets and department stores segment have the maximum market coverage as women prefer the place for its ability to display options.

Feminine Hygiene Market Regional Analysis:

The Asia Pacific region is expected to move forward as the market is witnessing a strong hike in demand for the product. This is primarily due to the hike in disposable income, better awareness, high level of proliferation of the major brands in several core regions, government initiatives to increase the level of awareness and others. Developing countries from the region are taking measures to support the growing need for female hygiene.

The Americas are expected to benefit from high penetration of products like tampons, internal cleansers, panty liners, hike in a number of working women, and a rise in demand for organic and biodegradable products. The market would also gain substantially from innovations and a high level of investment influx for research-related plans.

Europe would gain much from the growing disposable income and hike in demand for eco-friendly products. The growing attention towards bio-degradable products would boost the market prospect. In the Middle East & Africa, this growth would be hindered by a lack of awareness and poor economic structure. Various NGOs and companies are taking substantial measures to increase the awareness level, which may boost the market.

Feminine Hygiene Market Competitive Landscape:

The global market for female hygiene is expecting substantial growth in the coming years due to the increasing strategic participation from companies like Edgewell Personal Care, Procter and Gamble, Kimberly-Clark Corporation, Unicharm Corporation, Svenska Cellulosa Aktiebolaget SCA, Lil-Lets Group Ltd, Ontex International, Natracare LLC, Johnson & Johnson, and Kao Corporation. These strategies would include several steps like mergers, acquisitions, collaborations, innovations, and other forms.

Feminine Hygiene Industry News:

In February 2020, Sanfe raised substantial capital to take its product to regions like European and African continents in their Pre-Series A funding. In their venture, they are expected to receive funding from BIRAC, Elixir Pharma, SucSEED Venture Partners, and Titan Capital. The attempt would see the strengthening of the existing team and the product research wing.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/feminine-hygiene-market-7986

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

E-Clinical Solution Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “eClinical solutions Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

The report Global e-Clinical Solution comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance.

Increasing adoption of technologically advanced solutions and emphasis on automation have aided the healthcare sector in optimizing various functions and services especially in clinical trials and clinical research. eClinical solutions are utilized to carry out electronic data capturing and processing with the help of automation. Market Research Future (MRFR) has published a report stating that the global eClinical solutions market is marked to expand at a significant CAGR of 11.10% during the forecast period of 2018-2022.

Also read : https://www.medgadget.com/2019/01/global-eclinical-solutions-market-to-expand-at-a-significant-cagr-of-11-10-during-2019-to-2022-size-share-growth-demand-key-players-overview-business-insights-by-mrfr.html

Rapid increase in patient population and high prevalence of chronic diseases are inducing high demand for optimization of healthcare services. Incorporation of automation, recent development in artificial intelligence and machine learning technologies are some of the major factors that are propelling the growth of the global eClinical solutions market. Increased government funding for the development of healthcare services in the developed and developing regions and high demand for a sophisticated platform to manage a large amount of data from clinical research, and clinical trials are also fueling the growth of the global eClinical solutions market. However, poor economic conditions and low penetration of advanced technology in the underdeveloped regions are restraining the growth of the global eClinical solutions market during the assessment period.

Key Players:

The major players profiled by MRFR that are operating in the global eClinical solutions market are Oracle Corporation, Parexel International Corporation, eClinical Solutions Inc, Medidata Solutions Inc, Bioclinica Inc, CRF Health, Datatrak International, Merge Healthcare Inc, Omnicomm Systems Inc, Maxisit Inc, and ERT Clinical. The innovative initiatives such as advanced solution launch, strategic mergers and acquisitions, and increased research and development expenditure are aiding the players to sustain the competition and expand their businesses in the global eClinical solutions market.

The Global E-Clinical Solution Market appears to be highly competitive and diversified with the presence of giant manufacturers of the device, playing on the global level. These players are heavily investing in R&D, global expansion, advanced technologies and product Launch to gain the competitive edge in the market.

eClinical Solution Industry Related News:

In November 2018, Medidata, a leading provider of software as a service solution for clinical trials, announced a partnership with Hengrui Pharma, one of China’s largest biotech companies, to deliver innovative therapies and accelerate global drug research. Hengrui has adopted the Medidata cloud platform clinical trial management system which would support Hengrui to expand its drug therapies to patients around the world.

In September 2018, Veeva Systems, a provider of cloud-based solutions for the global life sciences industry, announced the launch of an advanced cloud-based clinical data management application to streamline and accelerate clinical study execution. The application can single-handedly manage all trial data and also includes Vault CTMS, Vault eTMF, and Vault Study Startup which helps unify all operations.

April 03, 2018 – MedNet Solutions (US), a leading cloud-based eClinical technology company launched its latest eClinical solution – iMedNet, a proven SaaS (Software-as-a-Service) clinical research technology platform that delivers an entire suite of eClinical tools to support clinical trial thoroughly (from start to finish).

February 9, 2018 – Oracle Corporation (US), technology giant launched its new Cloud-Based eClinical Solution – Clinical One Platform. The solution allows unified clinical development operations and information in a single environment with shared functions along with an easy-to-use interface for sites, clinical coordinators, and their counterparts.

Segmentation:

The Global eClinical Solutions Market has been segmented on the basis of product, delivery mode, and end-users. Based on product, the eClinical solutions market has been segmented into analytics platform, randomization & trial supply management systems (RTMS), clinical trial management systems (CTMS), electronic data capture (EDC), clinical data management systems (CDMS), clinical data integration platforms, electronic clinical outcome assessment (ECOA), safety solutions and electronic trial master files (ETMF). Based on delivery mode, the eClinical solutions market has been segmented into web-hosted (on demand), licensed enterprise (on-premise) and cloud-based (SaaS). Based on end-users, the eClinical solutions market has been segmented into contract research organizations, medical device manufacturers, consulting service companies, hospitals, pharmaceutical companies, and academic research organizations.

Regional Analysis:

The gGlobal eClinical Solutions Market has been geographically segmented into four major regions such as North America, Asia Pacific, Europe, and the rest of the world. The North America region is anticipated to command the largest share in the global eClinical solutions market. Rising demand for technologically advanced solutions in the healthcare sector, easy adoption of advanced technology and increasing number of ongoing clinical trials along with financial support from the government are aiding the growth of the eClinical solutions market in this region.

The Asia Pacific region is projecting the fastest growth at the highest CAGR in the global eClinical solutions market during the assessment period. The eClinical solutions market in this region is majorly driven by rapid development of the healthcare sector in the emerging economies and increasing outsourcing of services by the prominent multinational pharmaceutical organizations in this region. Increased investments in research and development in the well-developed healthcare sector are propelling the growth of the global eClinical solutions market.

The Middle East and Africa region commands the least share in the global eClinical solutions market owing to the low penetration of advanced technology in the underdeveloped countries of this region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eclinical-solution-market-2294

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Lancet Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

Market Research Future adds the “Lancet Market Research Report - Forecast to 2023” report to their unique collection.

F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Greiner Bio One International GmbH, Improve Medical Technology Co. Ltd, Terumo Medical Corporation, HTL-STREFA S.A, Sarstedt AG & Co are some of the prominent players competing in the Global Lancet Market and are profiled in MRFR Analysis.

Also Read : https://www.prnewswire.com/news-releases/lancet-market-evaluated-to-observe-a-sharp-growth-of-usd-28826-million-by-2022-at-113-of-cagr-300493478.html

Global Lancet Market - Overview

The Global Lancet Market is growing rapidly because of the rising prevalence of diabetes and growing number of blood borne diseases across the globe. According to a recent study report published by the Market Research Future, the global Lancet Market has been increasing. The market is expected to grow at a rapid pace during the forecast period (2016 – 2022). The Lancet Market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2016 – 2022). With such a pace MRFR asserts that the global Lancet market will reach USD 2,882.6 million in 2022 and is expected to grow with a CAGR of approximately 11.3% during the forecast period.

The Lancet industry is dynamic and essential component of the health care sector. Advances in technology improve medical devices to simplify the prevention, diagnosis and treatment of diseases. Globally lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues and many other issues. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. Technological advancement and increasing demand for effective and advance technology-based products is anticipated to boost the market size of Global Lancet Market. If the current trends in diabetes prevalence continues over the coming years, the number of diabetic patients would grow tremendously after a decade. With increasing diabetic prevalence, the demand of lancets is expected to be enormous, thus resulting in the increasing demand for devices and products to monitor and control diabetes, eventually leading to increased consumption of lancets. Sharps/ needle injury, also sometimes called as a percutaneous injury OSHA reports that nearly 55% of all percutaneous injuries are caused by hollow bore needles including phlebotomy needles. Additionally, growing prevalence of Needle bore injuries and Infectious Diseases for instance HIV are providing impetus to the market growth of Lancet Market as Lancets are designed for single use and to reduce or eliminate the risk of exposure to blood-borne pathogens.

The global lancet market has been evaluated as swiftly growing market in the coming future and it is expected that the market will have high demand globally. The global lancet market is undergoing a rapid change. Current discussions and proceedings have brought into examination's the competence of existing regulatory frameworks for medical devices in developed and developing regions to guarantee the devices performance, quality and safety. Medical device regulation must be enhanced and improved to safeguard public/patient health and ensure that effective technologies and high-quality products reach patients.

Global Lancet Market- Competitive Analysis

Characterized by the presence of several well-established and small players, the global Market of Lancer appears to be highly fragmented and competitive. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position. The Key players operating in the market compete based on pricing, product launch, technology launch, and reputation.

Manufacturers adopt modern manufacturing process to ensure safety and convenience. Marketers employ a continuous improvement strategy to analyze and update products, implementing improvements and launching new solutions to meet the changing needs of both patients and health care professionals. Manufacturers strive to fulfil the most restrictive hygienic and sterility standards while ensuring that the design of their products is defined by ergonomics, simplicity and reliability.

Global Lancet Market - Segments

The Lancet Market can be segmented in to 3 key dynamics for the convenience of the report and enhanced understanding;

Segmentation by Types: Comprises Personal, Safety and others.

Segmentation by End Users: Comprises Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, and others.

Segmentation by Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

On the basis of type, safety lancets account the largest market share in 2015 and is expected to reach USD 2,061.8 million by 2022.

Global Lancet Market - Regional Analysis

Globally North America is the largest market for Lancet. The North American market for Lancet is expected to grow at a CAGR of 11.2% during the forecasted period. This is due to increasing prevalence of diabetic patients. Europe is the second-largest market for Lancet with the market value of USD 592.8 million in 2015. Whereas Asia pacific is expected to be a growing market for Lancet market and expected to grow at a rapid rate.

Browse Related Report

The Global Safety Lancet Market is expected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/lancet-market-2078

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com